We found that PD-1 monoclonal antibodies can influence the expression of the PD-1/IRE1α/SHP2/HIF1α signaling pathway in TAMs and inhibit the migration and neovascularization of cervical cancer cells. The gene discussed is PDCD1; the disease is cervical cancer.